Background: A lifelong strict gluten-free diet is the only available treatment for celiac disease, but total exclusion of gluten is difficult to achieve. The aim of this study was to determine the range of time and the amount of gluten immunogenic peptides (GIP) excreted in urine after specific gluten ingestions. Methods: 20 healthy participants followed the same diet for 12 days in which 50 mg and 2 g of gluten were ingested and all the urinations were collected. GIP were analyzed by lateral flow immunoassay (LFIA) tests and quantified using an LFIA reader. Results: GIP were detected in 15% and 95% of participants after 50 mg and 2 g gluten intakes, respectively. The higher frequency and concentration of GIP was found between 6 and 9 ...
BACKGROUND: To determine the applicability and sensitivity of a urine self-test to detect gluten-imm...
Background: To determine the applicability and sensitivity of a urine self-test to detect gluten-imm...
Supported by Ministerio de Ciencia e Innovacion, No. DI-16-08943 and No. DI-17-09627.BACKGROUND Glu...
Background: A lifelong strict gluten-free diet is the only available treatment for celiac disease, b...
Background: A lifelong strict gluten-free diet is the only available treatment for celiac disease, b...
INTRODUCTION: The adherence to a gluten-free diet (GFD) is a trending topic in the management of cel...
INTRODUCTION: The adherence to a gluten-free diet (GFD) is a trending topic in the management of cel...
INTRODUCTION: The adherence to a gluten-free diet (GFD) is a trending topic in the management of cel...
INTRODUCTION: The adherence to a gluten-free diet (GFD) is a trending topic in the management of cel...
A gluten-free diet (GFD) is currently the only treatment available for patients with celiac disease ...
A gluten-free diet (GFD) is currently the only treatment available for patients with celiac disease ...
A gluten-free diet (GFD) is currently the only treatment available for patients with celiac disease ...
Gluten-free diet (GFD) is the only management for coeliac disease (CD). Available methods to assess ...
Purpose Determination of Gluten Immunogenic Peptides (GIP) in feces is a direct tool for gluten exp...
This work was supported by grants from Ministerio de Ciencia e Innovacion (DI-16-08943), Junta de An...
BACKGROUND: To determine the applicability and sensitivity of a urine self-test to detect gluten-imm...
Background: To determine the applicability and sensitivity of a urine self-test to detect gluten-imm...
Supported by Ministerio de Ciencia e Innovacion, No. DI-16-08943 and No. DI-17-09627.BACKGROUND Glu...
Background: A lifelong strict gluten-free diet is the only available treatment for celiac disease, b...
Background: A lifelong strict gluten-free diet is the only available treatment for celiac disease, b...
INTRODUCTION: The adherence to a gluten-free diet (GFD) is a trending topic in the management of cel...
INTRODUCTION: The adherence to a gluten-free diet (GFD) is a trending topic in the management of cel...
INTRODUCTION: The adherence to a gluten-free diet (GFD) is a trending topic in the management of cel...
INTRODUCTION: The adherence to a gluten-free diet (GFD) is a trending topic in the management of cel...
A gluten-free diet (GFD) is currently the only treatment available for patients with celiac disease ...
A gluten-free diet (GFD) is currently the only treatment available for patients with celiac disease ...
A gluten-free diet (GFD) is currently the only treatment available for patients with celiac disease ...
Gluten-free diet (GFD) is the only management for coeliac disease (CD). Available methods to assess ...
Purpose Determination of Gluten Immunogenic Peptides (GIP) in feces is a direct tool for gluten exp...
This work was supported by grants from Ministerio de Ciencia e Innovacion (DI-16-08943), Junta de An...
BACKGROUND: To determine the applicability and sensitivity of a urine self-test to detect gluten-imm...
Background: To determine the applicability and sensitivity of a urine self-test to detect gluten-imm...
Supported by Ministerio de Ciencia e Innovacion, No. DI-16-08943 and No. DI-17-09627.BACKGROUND Glu...